Detection of flowing growth cells (CTCs) in a breast cancer design was improved by an unique assay platform that uses a dual-receptor recognition and signal amplification strategy, researchers state. Reuters Health Details
Learn More
New Assay Platform Improves Detection of Distributing Breast Cancer Cells
